| Evidence | LOH in Kidney Neoplasms
- Parry L, Maynard JH, Patel A, Clifford SC, Morrissey C, Maher ER, Cheadle JP, Sampson JR Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas. Br J Cancer 2001 Oct 19;85(8):1226-30.
- Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D, Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D, Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitionalcell carcinoma of the bladder. Cancer Res 2003 Nov 15;63(22):7652-6.
LOH in Nephrosclerosis
Mutation in Nephrosclerosis
- van Slegtenhorst M, Verhoef S, Tempelaars A, Bakker L, Wang Q, Wessels M, Bakker R, Nellist M, Lindhout D, Halley D, van den Ouweland A, van Slegtenhorst M, Verhoef S, Tempelaars A, Bakker L, Wang Q, Wessels M, Bakker R, Nellist M, Lindhout D, Halley D, van den Ouweland A Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosiscomplex patients: no evidence for genotype-phenotype correlation. J Med Genet 1999 Apr;36(4):285-9.
Other key publications related to this gene
|
